MedPath

Early Detection of Aortic Stenosis in the Community During Flu Vaccination

Completed
Conditions
Aortic Stenosis
Registration Number
NCT03250806
Lead Sponsor
Institut für Pharmakologie und Präventive Medizin
Brief Summary

Prospective cohort study to test the hypothesis that patients identified with severe aortic stenosis are under-diagnosed and under-treated. Such patients shall be identified by auscultation or target echocardiography during flu vaccination. The hypothesis is that this will increase detection of aortic stenosis in the community.

Detailed Description

The design plans for two study phases:

1. Feasibility study: screening by auscultation and target echocardiography during flu vaccination in a single practice in Birmingham;

2. Screening study: multi-centre screening by auscultation or target echocardiography in geographically diverse general practices across the United Kingdom.

In each phase, the patient will be identified by auscultation and target echocardiography. Management and onward referral will be at the clinical discretion of the GP. Results of clinical review, investigation, follow-up and management will be recorded at 3 months from that date.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
167
Inclusion Criteria
  • Adults aged over 65years attending for influenza vaccination.
  • written informed consent to data collection
Exclusion Criteria
  • known aortic stenosis
  • previous aortic valve repair/replacement

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
comparison of detection rate of aortic stenosisFrom date of examination until follow-up after three months

Comparison of detection rates of aortic stenosis using target auscultation vs detection by target 2D echocardiography.

prevalence of aortic stenosisFrom date of examination until follow-up after three months

Determination of the prevalence of aortic stenosis detected on screening performed during flu vaccination.

Secondary Outcome Measures
NameTimeMethod
Evaluation of qualitative estimation of calcium burden on 2D echocardiography as a marker of AS severitythree months

Method evaluation

Calculation of costs in screening with auscultation versus target 2DE in screening for AS to inform future cost-efficacy studies of screening for AS.three months

Cost evaluation

Trial Locations

Locations (2)

Whaddon Medical Center

🇬🇧

Milton Keynes, Buckinghamshire, United Kingdom

Swanswell Medical Centre

🇬🇧

Birmingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath